Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rina Yagasaki
Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Related publications
Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)
Science-Business eXchange
Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases
Biomedical Journal
Medicine
Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy
Current Neurology and Neuroscience Reports
Neuroscience
Neurology
Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids
European Oncology and Haematology
Oncology
Hematology
Phosphoinositide-3 Kinase/Protein Kinase-B/Mammalian Target of Rapamycin Pathway in Psoriasis Pathogenesis. A Potential Therapeutic Target?
Acta Dermato-Venereologica
Dermatology
Medicine
LncRNA as a Therapeutic Target for Angiogenesis
Current Topics in Medicinal Chemistry
Medicine
Drug Discovery
Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Targeting the Mammalian Target of Rapamycin (mTOR): A New Approach to Treating Cancer
British Journal of Cancer
Cancer Research
Oncology
New Targets for Therapy in Breast Cancer: Mammalian Target of Rapamycin (mTOR) Antagonists
Breast Cancer Research
Cancer Research
Oncology